Missing/wrong data?
Log in to edit
Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial
scientific article published on 27 March 2017
Author/s
author: Ana Arance, Inge Marie Svane, Michele Maio, Caroline Robert, Virginia Ferraresi, Lars Bastholt, Dirk Schadendorf, Paolo Antonio Ascierto, Piotr Rutkowski, Andrzej Mackiewicz
Work details
Publication date
March 27, 2017
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.